Understanding how bilinguals with aphasia read in real-time after a stroke
Assessment of real-time reading comprehension in bilinguals with aphasia
This study looks at how people who speak two languages and have aphasia understand reading in both languages, using special eye-tracking tools to see how they process words and sentences, so we can better understand the challenges they face after a stroke.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11014967 on NIH RePORTER |
What this research studies
This research investigates how bilingual individuals with aphasia, a condition often resulting from a stroke, comprehend reading in their two languages. It uses eye-tracking technology to observe how these individuals process words and sentences in real-time, focusing on the cognitive-linguistic challenges they face. By examining the effects of semantic and lexical variables on their reading comprehension, the study aims to uncover the mechanisms of language selection and co-activation in bilinguals post-stroke.
Who could benefit from this research
Good fit: Ideal candidates for this research are bilingual individuals who have experienced a stroke and are currently facing challenges with reading comprehension due to aphasia.
Not a fit: Patients who are not bilingual or who have not experienced a stroke may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapeutic strategies for bilingual individuals with aphasia, enhancing their reading comprehension and overall communication abilities.
How similar studies have performed: Previous studies have successfully used eye-tracking methods in healthy bilinguals, but this specific approach with bilinguals who have aphasia is novel and untested.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Scimeca, Michael David — Boston University (Charles River Campus)
- Study coordinator: Scimeca, Michael David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.